Published online May 6, 2016. doi: 10.5527/wjn.v5.i3.283
Peer-review started: December 28, 2015
First decision: January 15, 2016
Revised: February 13, 2016
Accepted: March 22, 2016
Article in press: March 23, 2016
Published online: May 6, 2016
Processing time: 120 Days and 8.1 Hours
The diagnosis of small renal masses (SRMs) continues to increase likely attributable to widespread use of axial cross-sectional imaging. Many of these SRMs present in elderly patients with abnormal baseline renal function. Such patients are at risk for further decline following therapeutic intervention. Renal thermal ablation presents one approach for management of SRMs whereby tumors are treated in situ without need for global renal ischemia. These treatment characteristics contribute to favorable renal function outcomes following kidney tumor ablation particularly in patients with an anatomic or functional solitary renal unit.
Core tip: Because of increased abdominal imaging, an increasing number of incidental small kidney masses are being detected. Renal thermal ablation is one treatment strategy used for the management of these tumors. Oncologic outcomes in published series appear favorable. Thermal ablation allows treatment of kidney masses in situ without the need for complete ipsilateral renal ischemia. As a consequence, ablation may be an attractive alternative for patients with baseline kidney dysfunction owing to medical comorbidities who would be at risk for declining kidney function following surgery.